Literature DB >> 14610331

Association between brain natriuretic peptide and extracellular water in hemodialysis patients.

Riccardo Maria Fagugli1, Barbara Palumbo, Daniela Ricciardi, Paolo Pasini, Paola Santirosi, Luigi Vecchi, Franca Pasticci, Renato Palumbo.   

Abstract

BACKGROUND: Brain natriuretic peptide (BNP) is a hormone released by the left ventricle (LV) as a consequence of pressure or volume load. BNP increases in left ventricle hypertrophy (LVH), LV dysfunction, and it can also predict cardiovascular mortality in the general population as well as those undergoing hemodialysis (HD). We investigated the association between BNP and volume load in HD patients.
METHODS: We studied 32 HD patients (60 +/- 17.1 years) treated thrice-weekly for at least 6 months. Exclusion criteria were: LV dysfunction, atrial fibrillation, malnutrition. Blood chemistries and BNP were determined on mid-week HD day. Blood pressure (BP) and cardiac diameters were determined on mid-week inter-HD day by using 24-hour ambulatory blood pressure monitoring and echocardiography. Bioimpedance was performed after HD and extracellular water (ECW%), calculated as a percentage of total body water, was considered as the index of volume load.
RESULTS: Patients were divided into quartiles of 8 patients depending on the BNP value: 1st qtl BNP < or =45.5 pg/ml (28.4 +/- 10.9 pg/ml), 2nd qtl BNP > 45.5 pg/ml and < or =99.1 pg/ml (60.9 +/- 15.8 pg/ml), 3rd qtl BNP > 99.1 pg/ml and < or =231.8 pg/ml (160.5 +/- 51.8 pg/ml), 4th qtl BNP > 231.8 pg/ml (664.8 +/- 576.6 pg/ml). No inter-quartile differences were reported in age, HD age, body mass index spKt/V, or blood chemistries. As expected patients in the 4th BNP quartile showed the highest values of 24-hour pulse pressure (PP) and LV mass index (LVMi). The study of body composition revealed significant differences in ECW%, which was higher in the 4th quartile when compared to the others (4th q: 50 +/- 9.6%, vs 1st q. 40.1 +/- 2.4%, 2nd q. 41.9 +/- 5%, 3rd q. 42.8 +/- 6.9%). Using multiple stepwise linear regression where BNP was the dependent variable, and PP and ECW% the independent variables, only ECW% maintained statistical significance as a predictor of BNP levels (PP: Beta = 0.86, p = 0.58; ECW%: Beta = 0.64, p < 0.001 p < 0.001).
CONCLUSIONS: Few studies have investigated the relationship between plasma BNP and volume load, and direct evidence is lacking. We used bioimpedance and the determination of ECW% to assess volume state in HD patients finding an association between BNP and ECW. The increased synthesis and release of BNP from the LV in HD patients appear to be mainly related to volume stress rather than to pressure load. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14610331     DOI: 10.1159/000073669

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  17 in total

1.  N-terminal proBNP--marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients?

Authors:  John Booth; Jennifer Pinney; Andrew Davenport
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 8.237

2.  Comparison of markers of circulating blood volume in hemodialysis patients.

Authors:  Yoshiyuki Morishita; Yasuhiro Ando; Eriko Ishii; Mayumi Arisaka; Eiji Kusano
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

3.  N-terminal pro-B-type natriuretic peptide variability in stable dialysis patients.

Authors:  Magid A Fahim; Andrew Hayen; Andrea R Horvath; Goce Dimeski; Amanda Coburn; David W Johnson; Carmel M Hawley; Scott B Campbell; Jonathan C Craig
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-24       Impact factor: 8.237

4.  B-type natriuretic peptide is not a volume marker among patients on hemodialysis.

Authors:  Rajiv Agarwal
Journal:  Nephrol Dial Transplant       Date:  2013-03-22       Impact factor: 5.992

5.  Biomarkers in predicting mortality and treatment in hemodialysis patients.

Authors:  Angela Yee-Moon Wang
Journal:  F1000 Med Rep       Date:  2009-03-17

6.  Brain natriuretic peptide and P wave duration in dialysis patients.

Authors:  M Cagatay Taskapan; Soner Senel; Ozkan Ulutas; Yuksel Aksoy; Ibrahim Sahin; Feridun Kosar; Hulya Taskapan
Journal:  Int Urol Nephrol       Date:  2007-04-25       Impact factor: 2.370

7.  Predictive value of brain natriuretic peptides in patients on peritoneal dialysis: results from the ADEMEX trial.

Authors:  Ramon Paniagua; Dante Amato; Salim Mujais; Edward Vonesh; Alfonso Ramos; Ricardo Correa-Rotter; Walter H Horl
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-16       Impact factor: 8.237

8.  The role of natriuretic peptides in volume assessment and mortality prediction in Haemodialysis patients.

Authors:  Murugan Sivalingam; Enric Vilar; Suresh Mathavakkannan; Ken Farrington
Journal:  BMC Nephrol       Date:  2015-12-29       Impact factor: 2.388

9.  Relationship between Serum N-Terminal Pro-Brain Natriuretic Peptide Level and Left Ventricular Dysfunction and Extracellular Water in Continuous Ambulatory Peritoneal Dialysis Patients.

Authors:  Jong Hoon Chung; Na Ra Yun; Chi Yong Ahn; Wan Soo Lee; Hyun Lee Kim
Journal:  Electrolyte Blood Press       Date:  2008-06-30

10.  Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients.

Authors:  Sofia Sundqvist; Thomas Larson; Bruno Cauliez; Fabrice Bauer; Audrey Dumont; Frank Le Roy; Mélanie Hanoy; Caroline Fréguin-Bouilland; Michel Godin; Dominique Guerrot
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.